Skip to content

Clinical trials

Observational Leukemia, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Phase: Observational Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20103
20111
20131
20141
20153
20182
20223
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Unknown status4
Not yet recruiting2
Active, not recruiting1
Terminated1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
National Heart, Lung, and Blood Institute (NHLBI)2
Arkansas Children's Hospital Research Institute1
Asfendiyarov Kazakh National Medical University1
Astellas Pharma International B.V.1
Bristol-Myers Squibb1
European Society for Blood and Marrow Transplantation1
Genzyme, a Sanofi Company1
Gilead Sciences1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell22
Leukemia, Lymphocytic, Chronic, B-Cell9
Multiple Myeloma4
Lymphoma3
Lymphoma, Mantle-Cell3
Lymphoma, B-Cell, Marginal Zone2
Lymphoma, Non-Hodgkin2
Burkitt Lymphoma1
Hematologic Neoplasms1
Hyperplasia1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.